Allergenicity assessment of genetically modified organisms (GMOs )

Slides:



Advertisements
Similar presentations
Peanut Allergy 10% of children are sensitized but only 1-2% have symptoms Usually life-long Symptoms range from local reactions to anaphylaxis Very small.
Advertisements

Bischenberg, 23 rd September 2007The GA 2 LEN/EAACI Allergy School Effects of heat treatment and proteolytic enzymes on allergenicity Dr. Montserrat Fernández.
Assessment of Allergy Allergy testing Presented by Sylvie Daigle, RN, BSc Université de Montréal.
Literature support Test chart for the use of ImmunoCAP ® Allergen components Suspicion of fruit allergy Risk for severe reactions?
Are They Safe? Biotech Food Crops and Products February 1, 2002 Karen Pesaresi Penner Kansas State University Food Science Institute.
Hypersensitivity Hypersensitivity – Exaggerated immune response that have deleterious effects and causes damage to the individual. Anaphylaxis – an immediate.
Genetically Modified Soybeans: Equal Allergenicity as their Wild Type Counterparts? Katie Van Den Einde November 24, 2009 Advisor: Dr. Chastain.
Genetically Modified Organisms Interactions with Population Health and Safety Chelsea Kadish Tyler Vaughn Ashley Wright.
Hypersensivity Reactions
Allergy and Hypersensitivity K. J. Goodrum Types of Immune Hypersensitivity Reactions.
Soy Allergy Important protein source Sensitization frequency varies largely Prevalence of soy allergy % Symptoms –cuteaneous or gastrointestinal.
Risk assessment practice in the context of legislation and guidelines Armin Spök Inter-University Research Centre for Technology, Work and Culture (IFF/IFZ)
Literature support Test chart for the use of ImmunoCAP® Allergen components Suspicion of peanut allergy Risk for severe reactions?
BIOSAFETY CONCERNS IN THE CONTEXT OF BIOTECHNOLOGY. Presentation for Training Workshop for Regional Advisors Bangkok, Thailand May 2006.
BIOTECHNOLOGY AND GENETIC ENGINEERING IN VEGETABLE PRODUCTION Brittany Corey.
Establishment of National Genetically Modified Product Detection Laboratories and Detection Method Complex ZHU Shui-fang, Ph.D GMOs detection center Institute.
Genetically Modified Organisms (GMOs). Vocabulary (Write the following definitions in your notebook on PAGE 8) Genetically Modified Organism (GMO) – the.
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
HYPERSENSTIVITY Hypresensitivity causes reproducible symptoms and sings initiated by exposure to defined stimulus that is tolerated by „normal” people.
Foundation Training in Biological Safety. Module 4 Genetically modified organisms.
Hypersensitivity immunology. What is hypersensitivity?  the violent reaction of the immune system leading to severe symptoms and even death in sensitised.
Hypersensitivity Reactions: Definitions: Hypersensitivity reactions: inflammatory immune responses induced by repeated antigen exposure resulting in host.
Allergen regulation in the future : what will be the place for recombinant allergens ? Jacqueline DAYAN-KENIGSBERG European Academy of Allergology and.
Causes and Treatment of Atopic Dermatitis
Risk assessment: Bt corn MON810 Risk assessment: identifying and evaluating possible dangers predicting the chances the danger will occur assessing the.
TOPIC: Immunity AIM: How does the immune system protect the body against disease?
Hypersensitivity.
Historical overview Pr G. Pauli Hôpitaux Universitaires de Strasbourg Bischenberg 21 septembre 2007.
Type I Hypersensitivity (Allergy and Anaphylaxis.
Food Allergy & Food Intolerance. Allergy an abnormal reaction of the immune system to foreign (not infectious) material, leading to injury to the body.
Immunology Unit Department of Pathology College of Medicine King Saud University.
Immunopathology Dr JG Lawrenson. Immunopathology Hypersensitivity Autoimmunity Immunodeficiency © Dr JG Lawrenson 2001.
Hypersensitive Reactions. Immunopathology Exaggerated immune response may lead to different forms of tissue damage 1) An overactive immune response: produce.
TOPIC: Immunity AIM: How does the immune system protect the body against disease?
KEY CONCEPT Biotechnology relies on cutting DNA at specific places.
UNDERSTANDING CHEMICAL ALLERGEN POTENCY THROUGH THE MOLECULAR EVENTS THAT TRIGGER IMMUNE CELL ACTIVATION Elena Kummer.
Allergy and Hypersensitivity. Type I hypersensitivity: anaphylactic and atopic (Allergy) Allergens are small Ags, usually inocuous TH2 response intitiated.
Genetically Modified Foods Beth Roberson November 19, 2004 FST 490.
Immune responses that are inadequately controlled, inappropriately targeted to host tissues, or triggered by commensal microorganisms or usually harmless.
Prevalence of Asthma, Rhinitis and Eczema in Saudi Arabia * Physicians’ diagnosed Asthma + highly suspected asthma * * 1986: n=2123, 1995: n=1008, 2001:n=1014.
ALLERGIC REACTIONS. HYPERSENSITIVITY State of heightened immune reactivity What causes the problems Multistep Dormant Reaction (either or both) Antibody.
Hypersensitivity Type III and IV. Classification of Hypersensitivity TypeMechanismExample I IgE mediatedSystemic anaphylaxis eg peanut allergy Asthma.
FOOD ALLERGIES & INTOLERANCES LIFETIME NUTRITION & WELLNESS.
What are GMOs? Some technical background on the genetic modification of plants Stuart Brown Associate Professor NYU School of Medicine.
Genetically modified organisms (GMO). The states should label the genetically modified organisms to avoid the possible long term effects to the youth.
What are some other applications of genetically engineered organisms?
I. What is a Genetically Modified Organism (GMO)?
Biotechnology.
Suggested IgE ab testing of suspected soy allergic patients
Genetically Modified Foods (GMO)
Will genetically modified foods be allergenic?
Allergy In Dogs Things you should know
Biotechnology Objectives: At the end of this lecture we will be able to identify and describe the uses of biotechnology in society.
Biotechnology Genetic Engineering.
TOPIC: Immunity AIM: How does the immune system protect the body against disease?
Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening  Theresa Thalhamer, PhD, Heidi Dobias, MSc, Tatjana.
Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2  Fatima D. Ferreira,
Sabine Fischer, MSc,a, Monika Grote, PhD,b, B. Fahlbusch, PhD,c, W. D
Allergen-specific IgE production of committed B cells from allergic patients in vitro  Peter Steinberger, MSca, Barbara Bohlea, Franco di Padova, MDb,
Component-Resolved Diagnosis (CRD) of Type I Allergy with Recombinant Grass and Tree Pollen Allergens by Skin Testing  Susanne Heiss, Rudolf Valenta 
Component Resolved Diagnostics
Prevalence of Asthma, Rhinitis and Eczema in Saudi Arabia * Physicians’ diagnosed Asthma + highly suspected asthma * 1986: n=2123, 1995: n=1008, 2001:n=1014.
Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen:
Applications of Genetics and Ethical Concerns
Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for.
Skin test evaluation of a novel peptide carrier–based vaccine, BM32, in grass pollen– allergic patients  Verena Niederberger, MD, Katharina Marth, MD,
Introduction/Terminology
Will genetically modified foods be allergenic?
Profilin (Che a 2) and polcalcin (Che a 3) are relevant allergens of Chenopodium album pollen: Isolation, amino acid sequences, and immunologic properties 
Eva Untersmayr, MD, Erika Jensen-Jarolim, MD 
Presentation transcript:

Allergenicity assessment of genetically modified organisms (GMOs )

Some important definitions: Allergy: ”Overwhelming pathological reactions of the body due to intercurrent contact with antigens” Clemens von Pirquet 1906 IgE-mediated allergy is the most frequent form of allergy, but many other forms exist (e.g., celiac disease, immune complex diseases-Type III, cell-mediated forms of allergy-Type IV) Allergenic activity: Induction of an allergic reaction in allergic individual Allergenicity: Induction of allergy in a not yet allergic individual (i.e., sensitization and induction of allergic reactions)

Source of gene allergenic Yes Noo Sequence Homology Target Serum Screen Specific Serum Screen No Pepsin Resistance & Animal Models No +/+ +/- -/- High Low Probability of Allergenicity Likely Allergenic Yes No Yes Assessment of the allergenic potential of foods derived from biotechnology FAO/WHO decision tree

Current practice in the assessment of the allergenicity of GMOs Mainly arguments but rarely experiments Arguments against the allergenic potential of a GMO ·Lack of sequence homology with known allergens ·Inserted gene is expressed only at low levels ·Easily digestable protein ·Protein source is not an allergen source ·Lack of glycolsylation

Sequence comparisons are not suitable for predicting or excluding allergenicity with certainty

Human IgE and T cell reactivity patterns of Bet v 1 isoforms a, e, b, d, and l T cell reactivity (rel. %) IgE binding (rel. %) Skin prick test wheal areas (mm 2 ) nBet v ND rBet v 1a rBet v 1e rBet v 1l rBet v 1d rBet v 1b Isoforms of the major birch pollen allergen, Bet v 1 without allergic activity

T1, a Bet v 1-homologous plant protein without allergenic activity

The level of expression is not associated with allergenicity Example: Profilin, a potent cross-reactive plant allergen is expressed at low levels

Resistance to proteolytic digestion does not predict allergenicity Example: Pollen contains trypsin-labile as well as trypsin-resistant allergens

Glycosylation does not predict allergenicity Example: Phl p 7, a potent allergen from timothy grass pollen is not glycosylated

Pleiotropic effects affecting the overall allergenicity of the GMO must be considered Example: Upregulation of profilin expression during pollen maturation

The expression of PR-proteins, which represent important allergens, is regulated by various factors

Allergenic activity and allergenicity need to be assessed: Induction of allergic responses in experimental animal models

Suggestion: Evaluation of allergenicity by standardized experimental procedures Develop procedures for allergenicity assessment which can be applied for GMOs as well as for any other new organism

Investigation of the allergenic activity in allergic patients: IgE reactivity of extracts from GMOs and from the wildtype Assessment of allergenicity: Induction of IgE responses in animals with extracts from GMOs and from the wildtype Allergenic activity Investigation of whole GMOs NoYes Allergenicity

Thanks to: Armin Spök, Inter-University Research Center for Technology, Work and Culture, Graz, Austria. Helmut Gaugitsch, Federal Environment Agency, Vienna, Austria. Sylvia Laffer, Dept. of Pathophysiology, University of Vienna, Austria.